🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

PetMed Express And Crox Are Aggressive Growth Rank Buys

Published 09/07/2017, 05:03 AM
Updated 07/09/2023, 06:31 AM
US500
-
CROX
-
PETS
-

Brian Bolan, the aggressive growth stock strategist at Zacks Investment Research reviews two stocks that are both Zacks Rank #1 (Strong Buy) that also have growth style scores of “A.” This week Brian highlights PetMed Express (NASDAQ:PETS) and discusses the recent “short and distort” style report that was floated about the company a few weeks ago. Brian states that his experiences in buying medication for his pet Buckeye were the exact opposite of what the company was being accused of. Brian believes the stock is not a dog and will run higher. Crox (NASDAQ:CROX) is the next stock that is profiled and Brian speaks to higher earnings estimates. Terry notes that the shoes must be worn by more people than just chef’s – and Brian speaks to more types of shoes than the original being sold.

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>



PetMed Express, Inc. (PETS): Free Stock Analysis Report

Crocs, Inc. (CROX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.